KNSA Annual Current Liabilities
$63.67 M
+$16.60 M+35.27%
31 December 2023
Summary:
As of January 23, 2025, KNSA annual total current liabilities is $63.67 million, with the most recent change of +$16.60 million (+35.27%) on December 31, 2023. During the last 3 years, it has risen by +$31.82 million (+99.92%). KNSA annual current liabilities is now at all-time high.KNSA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNSA Quarterly Current Liabilities
$95.95 M
+$11.66 M+13.84%
30 September 2024
Summary:
As of January 23, 2025, KNSA quarterly total current liabilities is $95.95 million, with the most recent change of +$11.66 million (+13.84%) on September 30, 2024. Over the past year, it has increased by +$42.49 million (+79.46%). KNSA quarterly current liabilities is now at all-time high.KNSA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KNSA Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +35.3% | +79.5% |
| 3 y3 years | +99.9% | +178.7% |
| 5 y5 years | +49.6% | +248.2% |
KNSA Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +42.0% | at high | +162.3% |
| 5 y | 5-year | at high | +128.8% | at high | +396.1% |
| alltime | all time | at high | +2665.7% | at high | +450.5% |
Kiniksa Pharmaceuticals Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $95.95 M(+13.8%) |
| June 2024 | - | $84.29 M(+31.3%) |
| Mar 2024 | - | $64.21 M(+0.9%) |
| Dec 2023 | $63.67 M(+35.3%) | $63.67 M(+19.1%) |
| Sept 2023 | - | $53.47 M(+12.6%) |
| June 2023 | - | $47.47 M(+29.8%) |
| Mar 2023 | - | $36.59 M(-22.3%) |
| Dec 2022 | $47.07 M(+5.0%) | $47.07 M(-16.7%) |
| Sept 2022 | - | $56.49 M(+29.7%) |
| June 2022 | - | $43.54 M(-13.5%) |
| Mar 2022 | - | $50.35 M(+12.3%) |
| Dec 2021 | $44.82 M | $44.82 M(+30.2%) |
| Sept 2021 | - | $34.43 M(-11.2%) |
| June 2021 | - | $38.78 M(+9.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $35.45 M(+11.3%) |
| Dec 2020 | $31.85 M(+14.4%) | $31.85 M(+27.9%) |
| Sept 2020 | - | $24.89 M(+21.1%) |
| June 2020 | - | $20.55 M(+6.3%) |
| Mar 2020 | - | $19.34 M(-30.5%) |
| Dec 2019 | $27.83 M(-34.6%) | $27.83 M(+1.0%) |
| Sept 2019 | - | $27.56 M(-8.7%) |
| June 2019 | - | $30.18 M(-18.2%) |
| Mar 2019 | - | $36.89 M(-13.3%) |
| Dec 2018 | $42.55 M(+144.1%) | $42.55 M(+51.9%) |
| Sept 2018 | - | $28.02 M(+21.1%) |
| June 2018 | - | $23.14 M(+20.1%) |
| Mar 2018 | - | $19.27 M(+10.5%) |
| Dec 2017 | $17.43 M(+657.2%) | $17.43 M |
| Dec 2016 | $2.30 M | - |
FAQ
- What is Kiniksa Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals annual current liabilities year-on-year change?
- What is Kiniksa Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Kiniksa Pharmaceuticals?
- What is Kiniksa Pharmaceuticals quarterly current liabilities year-on-year change?
What is Kiniksa Pharmaceuticals annual total current liabilities?
The current annual current liabilities of KNSA is $63.67 M
What is the all time high annual current liabilities for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high annual total current liabilities is $63.67 M
What is Kiniksa Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, KNSA annual total current liabilities has changed by +$16.60 M (+35.27%)
What is Kiniksa Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of KNSA is $95.95 M
What is the all time high quarterly current liabilities for Kiniksa Pharmaceuticals?
Kiniksa Pharmaceuticals all-time high quarterly total current liabilities is $95.95 M
What is Kiniksa Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, KNSA quarterly total current liabilities has changed by +$42.49 M (+79.46%)